Valeant Pharmaceuticals International Inc (NYSE:VRX)

18.58
Delayed Data
As of 4:01pm ET
 -0.30 / -1.59%
Today’s Change
8.31
Today|||52-Week Range
24.43
-10.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-863.7M912.2M-287.8M-2.4B
 
 
 
 
 
Depreciation1.4B1.7B2.4B2.9B
 
 
 
 
 
Total Other Cash Flow1.4B319.1M849.0M1.9B
 
 
 
 
 
Funds From Operations1.4B3.0B2.9B2.1B
 
 
 
 
 
Funds From/For Other Operating Expenses378.3M668.4M822.2M110.0M
 
 
 
 
 
Net Cash Flow - Operating Activities1.0B2.3B2.1B2.0B
 
 
 
 
 
 
InvestingIncrease In Investments0.00-147.9M-49.3M-1.0M
 
 
 
 
Decrease In Investments17.0M129.1M66.7M17.0M
 
 
 
 
 
Capital Expenditures-115.3M-291.6M-235.2M-235.0M
 
 
 
 
 
Fixed Asset Disposal41.1M1.5B12.8M199.0M
 
 
 
 
 
Net Assets From Acquisitions -5.3B-1.1B-15.5B-19.0M
 
 
 
 
 
Other Investing - Uses0.000.00-26.3M-30.0M
 
 
 
Other Investing - Sources0.000.00184.6M0.00
 
 
Net Cash Flow Investing-5.4B-99.7M-15.6B-125.0M
 
 
 
 
 
 
FinancingShort Term Borrowings-47.7M-9.0M-300.0K3.0M
 
 
 
 
 
Long Term Borrowings8.3B1.6B17.8B1.2B
 
 
 
 
 
Long Term Debt Reduction-6.3B-3.9B-5.2B-2.4B
 
 
 
 
 
Net Proceeds Stock Sale2.3B17.2M1.5B33.0M
 
 
 
 
 
Common Preferred Redeemed-55.6M0.00-72.4M0.00
 
 
 
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing24.2M17.1M56.8M--
 
 
 
 
Other Uses - Financing197.7M158.4M301.9M683.0M
 
 
 
 
 
Net Cash Flow - Financing4.0B-2.4B13.8B-1.9B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-5.1M-29.0M-30.1M-54.0M
 
 
 
 
 
 
Net Change In Cash-310.7M-248.7M310.0M-1.0M